Effects of metformin on the adrenal cortex of androgenized rats

References

• Azziz R, Chang WY, Stanczyk FZ, Woods K. Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril 2013;99:599–604
   PubMed Web of Science ®Google Scholar
• Azziz R. Polycystic ovary syndrome: what's in a name? J Clin Endocrinol Metab 2014;99:1142–5
   PubMed Web of Science ®Google Scholar
• Jędrzejuk D, Laczmański L, Kuliczkowska J, et al. Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome. Gynecol Endocrinol 2014;5:1–4
   Google Scholar
• Dumesic DA, Richards JS. Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril 2013;100:23–38
   PubMed Web of Science ®Google Scholar
• Medeiros SF, Gil-Junior AB, Barbosa JS, et al. New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients. Arq Bras Endocrinol Metabol 2013;57:437–44
   PubMed Web of Science ®Google Scholar
• Michael AE, Glenn C, Wood PJ, et al. Ovarian 11β-hydroxysteroid dehydrogenase (11βHSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens. J Clin Endocrinol Metab 2013;98:3375–83
   PubMed Web of Science ®Google Scholar
• Krysiak R, Okopien B. The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. Exp Clin Endocrinol Diabetes 2014;10:568--71. Jul 23. [Epub ahead of print]. doi: 10.1055/s-0034-1382048
   Web of Science ®Google Scholar
• Johnson NP. Metformin use in women with polycystic ovary syndrome. Ann Transl Med 2014;2:56--61
   PubMedGoogle Scholar
• Leanza V, Coco L, Grasso F, et al. Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome. Minerva Ginecol 2014;66:299–301
   PubMedGoogle Scholar
• Howard-Jones N. A CIOMS ethical code for animal experimentation. WHO Chron 1985;39:51–6
   PubMedGoogle Scholar
• Silva BB, Lopes-Costa PV, Rosal MA, et al. Morphological and morphometric analysis of the adrenal cortex of androgenized female rats. Gynecol Obstet Invest 2007;64:44–8
   PubMed Web of Science ®Google Scholar
• Mahamed RR, Maganhin CC, Simões RS, et al. Effects of metformin on the reproductive system of androgenized female rats. Fertil Steril 2011;95:1507–9
   PubMed Web of Science ®Google Scholar
• Lombardi LA, Simões RS, Maganhin CC, et al. Morphology of the interstitial cells of rat polycystic ovaries: an experimental study. Rev Bras Ginecol Obstet 2012;34:323–8
   PubMedGoogle Scholar
• Moran C, Reyna R, Boots LS, Azziz R. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertil Steril 2004;81:126–31
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Carmina E, Azziz R. DHEA, DHEAS and PCOS. J Steroid Biochem Mol Biol. 2014;145:213--25. Jul 5. pii: S0960-0760(14)00117-4. doi: 10.1016/j.jsbmb.2014.06.003
   PubMed Web of Science ®Google Scholar
• Barraclough CA. Production of anovulatory, sterile rats by single injections of testosterone propionate. Endocrinology 1961;68:62–7
   PubMed Web of Science ®Google Scholar
• Doi SA, Towers PA, Scott CJ, Al-Shoumer KA. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod Biol 2005;118:4–16
   PubMed Web of Science ®Google Scholar
• Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:5925–33
   PubMed Web of Science ®Google Scholar
• Auchus RJ, Rainey WE. Adrenarche – physiology, biochemistry and human disease. Clin Endocrinol (Oxf) 2004;60:288–96
   PubMed Web of Science ®Google Scholar
• Doi SA, Al-Zaid M, Towers PA, et al. Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids 2006;71:751–9
   PubMed Web of Science ®Google Scholar
• McKenna IJ, Cuningham SK. Adrenal androgen production in polycystic ovary syndrome. Eur J Endocrinolol 1995;133:383–9
   PubMed Web of Science ®Google Scholar
• Zhang H, Legro RS, Zhang J, et al. Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod 2010;25:2612–21
   PubMed Web of Science ®Google Scholar
• Tokmak A, Kokanali MK, Guzel AI, et al. Polycystic ovary syndrome and risk of endometrial cancer: a mini-review. Asian Pac J Cancer Prev 2014;15:7011–14
   PubMed Web of Science ®Google Scholar
• Soares JM Jr, Simões MJ, Oshima CT, et al. Pinealectomy changes rat ovarian interstitial cell morphology and decreases progesterone receptor expression. Gynecol Endocrinol 2003;17:115–23
   PubMed Web of Science ®Google Scholar
• Lombardi LA, Simões RS, Maganhin CC, et al. Immunohistochemical evaluation of proliferation, apoptosis and steroidogenic enzymes in the ovary of rats with polycystic ovary. Rev Assoc Med Bras 2014;60:349–56
   PubMed Web of Science ®Google Scholar
• Legro RS. Polycystic ovary syndrome: the new millennium. Mol Cell Endocrinol 2001;184:87–93
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Khan KA, Stas S, Kurukulasuriya LR. Polycystic ovarian syndrome. J Cardiometab Syndr 2006;1:125–30
   PubMedGoogle Scholar
• Katsiki N, Hatzitolios AI. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update. Curr Opin Obstet Gynecol 2010;22:466–76
   PubMed Web of Science ®Google Scholar